|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH |
A Lazary, 1st Department of Medicine, Semmelweis University, Budapest, 1083, Hungary
J Kosa, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
B Tobias, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
J Lazary, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary
B Balla, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
K Bacsi, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
I Takacs, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
Z Nagy, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
T Mezo, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
G Speer, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
P Lakatos, 1st Department of Medicine, Semmelweis University, Budapest, Hungary
Correspondence: Aron Lazary, Email: lazary.aron{at}gmail.com
Abstract
Objective: Osteoporosis (OP) is a multifactorial disease with high heritability but its exact genetic background is still poorly understood. We examined the effect of twenty four single nucleotide polymorphisms (SNPs) located in five genes - alkaline phosphatase (ALPL), matrix metalloproteinase 2 (MMP2), tissue inhibitor of metalloproteases 2 (TIMP2), fibroblast growth factor receptor 1 (FGFR1) and fatty acid binding protein 3 (FABP3) - previously not associated with OP.
Design: We performed a genotype-phenotype association study at a university hospital.
Methods: 360 Hungarian postmenopausal women were involved in the study. Bone mineral density was determined at spine, hip and distal radius. Genomic DNA was extracted from venous blood samples and a high-throughput genotyping method based on single-based primer extension was applied for allelic discrimination. Robust statistical tools were utilized for multiplex data analysis.
Results: SNP rs6996321 in FGFR1 was significantly related to spine BMD (p=0.002) and rs10914367 in FABP3 was associated with hip BMD (p=0.028). Non-vertebral fracture risk was significantly increased in carriers of 'A' allele of rs9900972 in TIMP2 (OR=2.06, p=0.0187). We could also identify validated gene-gene interactions significantly affecting BMD and fracture risk.
Conclusions: We identified two previously not reported SNPs in FGFR1 and FABP3 associated with bone mineral density and a third SNP in TIMP2 related to risk for non-vertebral osteoporotic fractures. This is the first report on the association between these allelic variants and the phenotypes of postmenopausal osteoporosis. Further studies need to clarify the role of these genes and their polymorphisms in the process of bone loss.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |